Introduction
Mycobacterium tuberculosis (
M. tuberculosis), a causative agent of tuberculosis, is responsible for death of nearly 1.2 million HIV-negative individuals globally [
1]. Understanding the immune mechanism during latency, a state of persistent immune response to stimulation by
M. tuberculosis antigens [
2‐
4], has long been elusive for decades, while the global estimate shows just under a quarter (~ 23%) of the global population is labelled as latently infected [
5]. The host innate immune response is the first line of defence against invading pathogens and is vital for the initial defence against
M. tuberculosis and activation of the adaptive immune response [
6]. Toll-like receptors (TLRs) are a class of proteins that are single, membrane-spanning receptors mostly expressed on leukocytes, including macrophages that have significant role in TB pathogenesis, one of the antigen-processing cells and having a role during granuloma formation [
7]. These receptors generally recognize structurally conserved molecules derived from microbes such as bacteria and viruses [
8,
9] and mediate cell activation, leading to induction of pro inflammatory cytokines, dendritic cell maturation and apoptosis [
8,
10]. Due to lack of long lasting immunity, little attention has been given to understanding the role of innate immunity in protection against latent TB [
11]; however, this notion has now been changing with recent concepts of “trained immunity”, where some of the main features and traits of the adaptive immunity, such as specificity and memory, are also shared by innate markers [
12]. Identification of host biomarkers has long been a way forward in understanding the immunology of latent TB [
6] and contributing to development of these tools is of immense importance. To this effect, we aimed to evaluate the expression of selected TLR mRNAs in peripheral blood as correlates of immunity during latent TB infection.
Discussion
Early identification of individuals with LTBI, in particular those with a higher chance of progressing to a full blown active disease, is an important priority for TB control, especially in specific groups of population [
18]. Currently there is no gold standard test for LTBI. Tools, currently existing to-date to fully control TB, have remained to be inefficient and biomarkers have been considered as alternatives options. Recent studies have also demonstrated efforts to show improved tools to diagnose LTBI over existing immunodiagnostic tools such as the interferon gamma release assays (IGRA); one to mention, a novel IGRA assay, the LIOFeron TB/LTBI assay, that has proven to show a higher accuracy to diagnose MTB infection/TB disease compared to QuantiFERON TB Gold Plus [
19]. Nonetheless, despite extensive work to understand the role of adaptive immunity to
M. tuberculosis, efforts to understand the role of innate immunity, particularly the fact that it can remember a previous exposure to TB via TLRs has become profound in recent years [
20]. Toll-like receptors, one of the major innate immune markers, have been shown to be highly expressed during latent TB infection. These molecules are essential part of pattern-recognition receptor proteins expressed on the surface of the cell membrane or membrane of endocytic vesicles, having a role in the activation and triggering of pro-inflammatory cytokines, particularly in mycobacterial diseases [
21]. The apparent increase in the relative expression of TLRs markers among latently infected individuals could be an indication for their role in the recognition of
Mtb microbial components, such as lipoproteins, glycol-lipoprotein and lipomannan (LM) [
22‐
25]. To mention few, the roles of TLR-1, TLR-2 and TLR-6 have been reported in the recognition of triacylated lipopeptides and diacylated lipopeptides of
Mtb, TLR-4 in LPS recognition and TLR-9 homodimer in CPG DNA recognition [
26]. In the present study, we observed an increased expression of TLR-2, TLR-4, TLR-6, and TLR-9 mRNA in latently infected group compared to non-infected, possibly indicating their role during latent TB infection through continuous stimulation and priming of immune system. Other studies have also reported a similar finding, although no significant difference in the expression of these markers was noted between active TB patients and latently infected individuals [
27]. More studies have also indicated the occurrence of TLR stimulation that could result from interaction with circulating cytokines and modified by the cytokine milieu [
27‐
29]. Although further confirmatory studies are warranted, our observation of enhanced expression possibly suggest a preliminary evidence for trained immunity, where MTB could potentially reside in and train the myeloid progenitor cells that will later be recognized by these receptors in the peripheral circulation. Studies have also demonstrated that MTB resides in hematopoietic stem cells, suggesting similar priming roles both in humans and animal models [
30‐
34] and potentially leading to recognition of progenitors of the bacterial components by host TLRs in the blood circulation.
Toll-like receptor-2 often forms heterodimers with either TLR-1 or TLR-6, interacting with diacylated and triacylated lipoproteins, respectively [
35,
36], where heterodimers recognize mycobacterial cell wall glycolipids like lipoarabinomanna (LAM), LM and mycobacterial glycoprotein [
37]. To this effect, we compared ratios between TLR-2 and TLR-1 and TLR-6, where the ratios were significantly higher in latently-infected groups compared to those non-infected. The relative down regulation of TLR-1 gene in latently infected individuals could be related to the structural conformities required by TLR-1 to recognize microbial structures, as TLR-1 often needs TLR-2 to form a heterodimer to recognise microbial structures [
26]. Similar observations were also reported by others, where the mRNA expression of TLR-1 was reduced in latently infected individuals [
27].
Comparison of TLR expressions across age (between younger children and adolescents), however did not show any apparent difference. Since TLRs are mostly inborn immune receptors, expression of these markers across age may not be expected; however, exploring the expression of these genes across age may warrant further investigation with larger cohort to tease out immunological factors associated to higher incidences of TB infection among adolescents [
13,
38‐
40] compared to younger children and further understand the significance of trained immunity.
Analysis of intra-compartment receptors (TLR-9) and surface receptors (TLR-1, TLR-2, TLR-4, and TLR-6), showed a strong positive correlation. Despite wide range of ligands recognized by TLRs, these receptors have been shown to share a common structural framework in their extracellular, ligand-binding domains, leading to cascaded pathways for pro-inflammatory cytokine signalling [
24]. As a result, recognition of pathogen-associated patterns via TLRs direct the main pathways by which dendritic cells are activated and mature to provide signals to naive T cells and tailor specific immune responses [
41]. Similar evidence demonstrated that TLR-2 heterodimer with TLR-1, TLR-6 and TLR-4 have been implicated as receptors involved in the recognition of mycobacterial antigens and activation of macrophages and dendritic cells [
42]. On the other hand, synergic effects of polymorphisms between TLR-4 and TLR-9 has been shown to increase the risk of TB [
25,
43]. In our study, a strong correlation was observed between expression of surface receptors and intracellular TLRs. Though each receptors can activate different components of the immune system, the synrgic effect and the activation of TLRs by their respective ligands has an informative role in directing acquired immunity [
9,
10] and capable of modulating the adaptive immune response and differentiation of T cells [
44,
45].
In conclusion, the present study demonstrated that upregulation of specific TLR markers, particularly TLR-2 and TLR-6 during latency, possibly suggesting the role these markers play during latent TB infection to maintain the continuous priming of the immune system and monocytes emigrating into LTBI site in the lung and better able to sustain local immunity. Likewise, a strong correlation observed between endosomal receptors (like TLR-9) and surface TLRs during latency may show their role in maintaining the steady interaction between the dormant TB bacilli and host immunity. One could possibly argue an association between two variables (such as in this case between LTBI and TLR expression) in a cross-sectional study can simply imply cause-effect, while each variable could be casually related to a third or different underlying factor(s). Given that inflammatory biomarkers are normally distributed in a population, some individuals may always have higher biomarker levels than others, due to a number of usually unexplained reasons, some of which could also be associated with trained immunity or otherwise. It is also possible that associated underlying heightened immune mechanisms could simply contribute to increased ease to detect LTBI in one of two populations even though the true prevalence of latent TB in each population could be identical. Therefore, to further validate such observations designing studies in controlled groups such as before and after isoniazid therapy and also exploring the priming effect of MTB in milieu of myeloid progenitor cells is strongly warranted. In addition, exploring these and additional innate immune markers in a wider cohort of participants that also includes TB patients is warranted to elucidate whether these genes can be used as possible biomarkers in future booster TB vaccine trials.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.